Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 60 references it cites were found in a registry or an index; 32 of the 58 sources its claims cite were checked for support.

TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle

Open access

Abstract

Diet-induced insulin resistance (IR) adversely affects human health and life span. We show that muscle-specific overexpression of human mitochondrial transcription factor A (TFAM) attenuates high-fat diet (HFD)–induced fat gain and IR in mice in conjunction with increased energy expenditure and reduced oxidative stress. These TFAM effects on muscle are shown to be exerted by molecular changes that are beyond its direct effect on mitochondrial DNA replication and transcription. TFAM augmented the muscle tricarboxylic acid cycle and citrate synthase facilitating energy expenditure. TFAM enhanced muscle glucose uptake despite increased fatty acid (FA) oxidation in concert with higher β-oxidation capacity to reduce the accumulation of IR-related carnitines and ceramides. TFAM also increased pAMPK expression, explaining enhanced PGC1α and PPARβ, and reversing HFD-induced GLUT4 and pAKT reductions. TFAM-induced mild uncoupling is shown to protect mitochondrial membrane potential against FA-induced uncontrolled depolarization. These coordinated changes conferred protection to TFAM mice against HFD-induced obesity and IR while reducing oxidative stress with potential translational opportunities.

Overview

CoChat Summary

TL;DR

Muscle-specific overexpression of human TFAM in mice increased mtDNA copy number, fat oxidation, energy expenditure, and antioxidant defenses while attenuating high-fat diet–induced fat gain and insulin resistance. The effects involved TCA cycle/β-oxidation remodeling, reduced ROS, altered ETC complexes, and pAMPK/PPARβ/PGC-1α/GLUT4 pathways.

Key findings

  • In male FVB mice on a 12-week HFD (60% calories from fat), hTFAM transgenic mice gained less body weight and fat mass than wild-type mice, had higher metabolic rates during day and night, and showed less HFD-induced decline in insulin sensitivity by hyperinsulinemic-euglycemic clamp (GIR and muscle glucose uptake); blood glucose was lower in Tg HFD-fed mice than Wt HFD-fed mice.
  • TFAM increased mtDNA copy number and mitochondrial-encoded mRNAs and shifted mitochondrial bioenergetics: higher state 3 respiration with palmitoyl-carnitine/malate and lower with glutamate/malate; higher TCA cycle metabolites, citrate synthase, hexokinase activity, and lactate; lower ATP and creatine phosphate with higher ADP and AMP.
  • TFAM lowered mtH2O2 emissions regardless of diet, reduced ROS-mediated DNA damage and GSSG/GSH, and increased SOD2, catalase, and Cyt c; it enhanced complete β-oxidation (lower very long-, long-, and medium-chain acylcarnitines, higher short-chain acylcarnitines, higher LCAD) and prevented the HFD-induced increase in Cer18.
  • TFAM remodeled the ETC post-translationally (increased ATPsyn and SUO; decreased ND, CORE1, UCP3, and COX1 with increased ubiquitination), induced mild Δψm uncoupling/protection against FA-induced depolarization, and preserved insulin-stimulated pAKT while increasing pAMPK, PPARβ, PGC-1α, and GLUT4.

Methods

  • Generated muscle-specific hTFAM transgenic FVB mice using a muscle-specific creatinine kinase promoter; male Tg and Wt littermates were assigned to chow or HFD for 12 weeks.
  • Phenotyping included EchoMRI/DEXA body composition, indirect calorimetry, hyperinsulinemic-euglycemic clamp (120–130 mg/dL for 120 min; 16 mU/kg insulin bolus then 2.5 mU/kg/min), high-resolution respirometry, Amplex Red H2O2 measurement, RT-PCR, Western blots, immunoprecipitation, LC-MS lipid metabolites, NMR energy metabolites, TMRM membrane potential imaging, C2C12 myotube TFAM overexpression ± 0.2 mmol/L palmitate, and 3 μmol/L DNP treatment.
  • Statistics used Student t test, one-way ANOVA, two-way ANOVA, or Mann-Whitney rank sum test as appropriate, with significance denoted at *P < 0.05, P < 0.01, *P < 0.001, and P < 0.0001.

Limitations

  • Stated: only male animals were used to avoid confounding effects of fluctuating female hormones on outcomes.
  • Stated: hTFAM has >70% sequence homology to mouse TFAM and conserved DNA-binding domains, but effects related to species differences cannot be fully excluded.
  • Evident: findings are from a transgenic mouse overexpression model and C2C12 myotubes, not human skeletal muscle; several mechanistic links are inferred from associations and cell-line experiments rather than direct causal testing in vivo.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2337/db19-0088

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

24 Valid · 3 Not valid · 24 Not checked · 158 Own results and interpretations

115 more claims · 7 with their cited sources checked

Create a free account to see all 209 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 69
  • Probably not a substantial claim. 33
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 60 references

Cited by

See all 92

Metadata

Authors
Koh, J.-H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., Lanza, I. R., & Nair, K. S.
Affiliations
  • Mayo Clinic (US)
  • Mayo Clinic Regional Comprehensive Metabolomics Core, Mayo Clinic, Rochester, MN
  • Yale University (US)
Corresponding author
Nair, K. Sreekumaran
Venue
Diabetes
Published
2019-05-14
Volume
68
Issue
8
Pages
1552-1564
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2944967886
Cited by
92
References
60
Citations by year
2026: 9 · 2025: 11 · 2024: 12 · 2023: 23 · 2022: 14 · 2021: 13 · 2020: 7 · 2019: 2
FWCI
2.98
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Center for Scientific Review (DK-007198, TRDK-007352, RO1-DK-41973, U24-DK-100469)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
TFAM, insulin resistance, high-fat diet, skeletal muscle, fat oxidation, fatty acid beta-oxidation, energy expenditure, TCA cycle, citrate synthase, glucose uptake, L-carnitine, ceramide, AMPK, PGC-1α, PPARδ, GLUT4, Akt, mitochondrial uncoupling, mitochondrial membrane potential, oxidative stress, obesity, mitochondrial DNA
MeSH terms
Animals, Body Composition, DNA-Binding Proteins, Female, High Mobility Group Proteins, Hydrogen Peroxide, Insulin Resistance, Male, Mitochondria, Magnetic Resonance Spectroscopy, Oxidation-Reduction, RNA, Messenger, Blotting, Western, Muscle, Skeletal, Muscle Fibers, Skeletal, Immunoprecipitation, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle. https://app.cochat.ai/papers/10.2337/db19-0088
The paper
Koh, J.-H., Johnson, M. L., Dasari, S., LeBrasseur, N. K., Vuckovic, I., Henderson, G. C., Cooper, S. A., Manjunatha, S., Ruegsegger, G. N., Shulman, G. I., Lanza, I. R., & Nair, K. S. (2019). TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet–Induced Insulin Resistance in Skeletal Muscle. Diabetes. https://doi.org/10.2337/db19-0088

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.